COV 5.41% 35.0¢ cleo diagnostics ltd

Ann: COV Ovarian Cancer Blood Test Outperforms Clinical Benchmark, page-61

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 9,599 Posts.
    lightbulb Created with Sketch. 171
    i dissagree

    you say

    The fact that they can test it before removal is simply not that big of a deal

    i say

    it is a big deal to the hospital, doctor and the patient

    just imagine how much an operation to remove a (or multiple) tumor (s) would cost...ya gotta pay for the Doctors, Anesthetist, nurses...etc

    now, how much money would you save if you could just have a test instead to determine if it was actually necessary...and half are not

    it may not be much revenue for COV...but if they could trademark it...it could be worth big bickies
 
watchlist Created with Sketch. Add COV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.